Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Revenue

Madrigal Pharmaceuticals had revenue of $311.34M in the quarter ending March 31, 2026, with 126.84% growth. This brings the company's revenue in the last twelve months to $1.13B, up 256.82% year-over-year. In the year 2025, Madrigal Pharmaceuticals had annual revenue of $958.40M with 432.05% growth.

• Revenue (ttm): $1.13B
• Revenue Growth: +256.82%
• P/S Ratio: 10.53
• Revenue / Employee: $1,237,694
• Employees: 915
• Market Cap: 11.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	958.40M	778.27M	432.05%
Dec 31, 2024	180.13M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	147.00K	-7.44M	-98.06%
Dec 31, 2011	7.58M	-7.22M	-48.77%
Dec 31, 2010	14.80M	-129.44M	-89.74%
Dec 31, 2009	144.25M	141.63M	5,416.06%
Dec 31, 2008	2.62M	1.87M	251.95%
Dec 31, 2007	743.00K	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 23, 2026

Data Sources Report a data error